Subba R. Digumarthy

2006–2026 年に発表

111
論文数
22,689
被引用数
57
h 指数
103
i10 指数

被引用数

Subba R. Digumarthy の年別被引用数1945 年: 被引用 1 件1989 年: 被引用 1 件2001 年: 被引用 1 件2004 年: 被引用 1 件2007 年: 被引用 1 件2008 年: 被引用 34 件2009 年: 被引用 93 件2010 年: 被引用 138 件2011 年: 被引用 202 件2012 年: 被引用 256 件2013 年: 被引用 322 件2014 年: 被引用 271 件2015 年: 被引用 251 件2016 年: 被引用 253 件2017 年: 被引用 303 件2018 年: 被引用 289 件2019 年: 被引用 789 件2020 年: 被引用 915 件2021 年: 被引用 968 件2022 年: 被引用 806 件2023 年: 被引用 638 件2024 年: 被引用 931 件2025 年: 被引用 487 件2026 年: 被引用 22 件1946〜1988 年は被引用が無いため表示していません1990〜2000 年は被引用が無いため表示していません2002〜2003 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,857 件、この内訳の 26.9%中国: 引用元論文 1,594 件、この内訳の 15%イタリア: 引用元論文 548 件、この内訳の 5.2%イギリス: 引用元論文 482 件、この内訳の 4.5%日本: 引用元論文 481 件、この内訳の 4.5%ドイツ: 引用元論文 429 件、この内訳の 4.1%フランス: 引用元論文 412 件、この内訳の 3.9%韓国: 引用元論文 391 件、この内訳の 3.7%スペイン: 引用元論文 321 件、この内訳の 3%カナダ: 引用元論文 301 件、この内訳の 2.8%オランダ: 引用元論文 250 件、この内訳の 2.4%オーストラリア: 引用元論文 237 件、この内訳の 2.2%
0%26.9%その他 21.8%

分野

  • Medicine72%
  • Biochemistry, Genetics and Molecular Biology18%
  • Engineering5.9%
  • Immunology and Microbiology1.3%
  • Computer Science0.8%
  • Chemistry0.5%
  • その他1.5%

トピック

  • Lung Cancer Treatments and Mutations13.7%
  • Lung Cancer Research Studies6.8%
  • Cancer Genomics and Diagnostics6.4%
  • Lung Cancer Diagnosis and Treatment5.1%
  • Cancer Immunotherapy and Biomarkers4.7%
  • Cancer Cells and Metastasis4.6%
  • その他58.7%

共著者

全論文

検索で開く
  1. Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2011 被引用: 3,556

  2. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 被引用: 367

  3. EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 1,241

  4. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A. Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlési, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric‐Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis - Cancer Discovery 2023 被引用: 181

  5. Isolation of rare circulating tumour cells in cancer patients by microchip technology

    著者: , , , , , , , , , , , , , , - Nature 2007 被引用: 3,556

  6. Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mari Mino–Kenudson, Jeffrey A. Engelman, Alice T. Shaw - Cancer Discovery 2016 被引用: 1,144

  7. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian S. Henick, Naiyer A. Rizvi, Pasi A. Jänne, Mark M. Awad, Andrew Chow, Benjamin D. Greenbaum, Marta Łuksza, Alice T. Shaw, Jedd D. Wolchok, Nir Hacohen, Gad Getz, Justin F. Gainor - Nature Genetics 2023 被引用: 186

  8. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 1,882

  9. Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 336

  10. CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Collin M. Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Matthias Scheffler, Subba R. Digumarthy, Meghan J. Mooradian, Adrian G. Sacher, Sally C. M. Lau, Andreas Saltos, Julia Rotow, Rocio Perez Johnson, Corinne Liu, Tyler F. Stewart, Sarah B. Goldberg, Jonathan Killam, Zenta Walther, Kurt A. Schalper, Kurtis D. Davies, Mark G. Woodcock, Valsamo Anagnostou, Kristen A. Marrone, Patrick M. Forde, Biagio Ricciuti, Deepti Venkatraman, Eliezer M. Van Allen, Amy L. Cummings, Jonathan W. Goldman, Hiram Shaish, Melanie Wain Kier, Sharyn I. Katz, Charu C. Aggarwal, Ying Ni, Joseph T. Azok, Jeremy Segal, Lauren L. Ritterhouse, Joel W. Neal, Ludovic Lacroix, Yasir Y. Elamin, Marcelo V. Negrão, Xiuning Le, Vincent K. Lam, Whitney E. Lewis, Haley N. Kemp, Brett Carter, Jack A. Roth, Stephen G. Swisher, Richard Lee, Teng Zhou, Alissa Poteete, Yifan Kong, Tomohiro Takehara, Alvaro Guimaraes Paula, Edwin R. Parra, Carmen Behrens, Ignacio I. Wistuba, Jianjun Zhang, George R. Blumenschein, Carl M. Gay, Lauren A. Byers, Don L. Gibbons, Anne S. Tsao, J. Jack Lee, Trever G. Bivona, D. Ross Camidge, Jhannelle E Gray, Natasha B. Leighl, Benjamin Levy, Julie R. Brahmer, Marina Chiara Garassino ほか 31 名 - Nature 2024 被引用: 155

  11. Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 被引用: 127

  12. Association of Artificial Intelligence–Aided Chest Radiograph Interpretation With Reader Performance and Efficiency

    著者: , , , , , , , , , , , , , , , - JAMA Network Open 2022 被引用: 132

  13. Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2023 被引用: 91

  14. Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2019 被引用: 238

  15. Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion–Positive Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 139

  16. Landscape of Acquired Resistance to Osimertinib in EGFR -Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 被引用: 445

  17. An Artificial Intelligence–Based Chest X-ray Model on Human Nodule Detection Accuracy From a Multicenter Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2021 被引用: 106

  18. Image Quality and Lesion Detection on Deep Learning Reconstruction and Iterative Reconstruction of Submillisievert Chest and Abdominal CT

    著者: , , , , , , , , , , - American Journal of Roentgenology 2020 被引用: 241

  19. MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 194

  20. Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence

    著者: , , , , - Clinical Chemistry 2024 被引用: 70

  21. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs

    著者: , , , , - JAMA Network Open 2020 被引用: 122

  22. Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 413

  23. Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade

    著者: , , , , , , , , , , , , , , , - Cancer Discovery 2020 被引用: 68

  24. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 被引用: 1,614